Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Huntington Disease | 5 | 2021 | 141 | 0.620 |
Why?
|
| tau Proteins | 3 | 2023 | 189 | 0.420 |
Why?
|
| Myotonic Dystrophy | 1 | 2013 | 145 | 0.380 |
Why?
|
| Huntingtin Protein | 4 | 2021 | 61 | 0.380 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 573 | 0.370 |
Why?
|
| Tauopathies | 2 | 2023 | 56 | 0.330 |
Why?
|
| Nerve Tissue Proteins | 4 | 2012 | 1114 | 0.220 |
Why?
|
| Drosophila Proteins | 3 | 2021 | 707 | 0.200 |
Why?
|
| Electrical Synapses | 1 | 2021 | 8 | 0.190 |
Why?
|
| Alzheimer Disease | 4 | 2023 | 764 | 0.170 |
Why?
|
| Protein Kinase C beta | 1 | 2019 | 21 | 0.160 |
Why?
|
| Neuroglia | 1 | 2021 | 193 | 0.160 |
Why?
|
| Drosophila | 7 | 2023 | 766 | 0.160 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 348 | 0.160 |
Why?
|
| Protein Kinases | 2 | 2019 | 330 | 0.160 |
Why?
|
| Amyloidosis | 1 | 2019 | 65 | 0.150 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2019 | 121 | 0.150 |
Why?
|
| Behavior, Animal | 2 | 2021 | 478 | 0.150 |
Why?
|
| Nuclear Proteins | 3 | 2010 | 1265 | 0.150 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 96 | 0.150 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 206 | 0.140 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 73 | 0.140 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 4275 | 0.140 |
Why?
|
| Brain | 4 | 2023 | 2964 | 0.140 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2016 | 16 | 0.140 |
Why?
|
| RNA Interference | 2 | 2019 | 496 | 0.130 |
Why?
|
| alpha-Synuclein | 1 | 2016 | 114 | 0.130 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 571 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 2 | 2007 | 253 | 0.120 |
Why?
|
| Cell Nucleus | 1 | 2016 | 675 | 0.110 |
Why?
|
| Myoblasts | 1 | 2013 | 30 | 0.110 |
Why?
|
| ras Proteins | 1 | 2012 | 136 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2016 | 810 | 0.100 |
Why?
|
| Animals | 12 | 2023 | 33767 | 0.090 |
Why?
|
| Drosophila melanogaster | 4 | 2021 | 738 | 0.090 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 64 | 0.090 |
Why?
|
| Mice | 7 | 2023 | 17512 | 0.080 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2007 | 9 | 0.070 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2007 | 124 | 0.070 |
Why?
|
| Fragile X Syndrome | 1 | 2007 | 150 | 0.070 |
Why?
|
| Ubiquitin | 1 | 2006 | 141 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 2391 | 0.060 |
Why?
|
| Cell Line | 2 | 2021 | 2771 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2017 | 3042 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2526 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2019 | 1608 | 0.060 |
Why?
|
| Transcriptome | 2 | 2021 | 902 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 352 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2018 | 880 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 664 | 0.050 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2023 | 17 | 0.050 |
Why?
|
| Neurons | 4 | 2017 | 1937 | 0.050 |
Why?
|
| Humans | 11 | 2023 | 123036 | 0.050 |
Why?
|
| Corpus Striatum | 2 | 2012 | 89 | 0.050 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2021 | 83 | 0.050 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2021 | 78 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 3274 | 0.050 |
Why?
|
| Locomotion | 1 | 2021 | 69 | 0.050 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 92 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 63 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 351 | 0.040 |
Why?
|
| Models, Biological | 2 | 2017 | 1444 | 0.040 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2017 | 26 | 0.040 |
Why?
|
| Mutation | 3 | 2021 | 5771 | 0.040 |
Why?
|
| Ataxins | 2 | 2007 | 114 | 0.040 |
Why?
|
| Proteolysis | 1 | 2017 | 165 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 350 | 0.030 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2016 | 29 | 0.030 |
Why?
|
| Ataxin-1 | 2 | 2007 | 164 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 190 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 312 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 458 | 0.030 |
Why?
|
| Fear | 1 | 2016 | 202 | 0.030 |
Why?
|
| Peptides | 2 | 2010 | 794 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2019 | 678 | 0.030 |
Why?
|
| Autophagy | 1 | 2017 | 390 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3240 | 0.030 |
Why?
|
| Farnesyltranstransferase | 1 | 2012 | 9 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2019 | 995 | 0.030 |
Why?
|
| Triazoles | 1 | 2012 | 138 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 184 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1680 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2010 | 74 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 170 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 740 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2012 | 373 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2016 | 671 | 0.020 |
Why?
|
| Caspases | 1 | 2010 | 158 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 243 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 256 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 1068 | 0.020 |
Why?
|
| Mitochondria | 1 | 2012 | 677 | 0.020 |
Why?
|
| CELF1 Protein | 1 | 2007 | 48 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 153 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 198 | 0.020 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2007 | 125 | 0.020 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2006 | 13 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 316 | 0.020 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2006 | 58 | 0.020 |
Why?
|
| Genome, Human | 1 | 2012 | 1264 | 0.020 |
Why?
|
| Eye | 1 | 2007 | 227 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2006 | 167 | 0.020 |
Why?
|
| Protein Folding | 1 | 2006 | 218 | 0.020 |
Why?
|
| Transgenes | 1 | 2006 | 334 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2006 | 834 | 0.010 |
Why?
|
| Male | 2 | 2021 | 60069 | 0.010 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2006 | 253 | 0.010 |
Why?
|
| Female | 2 | 2021 | 65500 | 0.010 |
Why?
|
| Adult | 1 | 2023 | 29014 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 4489 | 0.010 |
Why?
|